NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 11651.50 -74.65 -0.64%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Amsurg Corp. (NASDAQ: AMSG)

 
AMSG Technical Analysis
2
As on 1st Dec 2016 AMSG Share Price closed @ 67.81 and we RECOMMEND Sell for LONG-TERM with Stoploss of 71.14 & Strong Buy for SHORT-TERM with Stoploss of 64.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AMSG Share Price

Open 68.12 Change Price %
High 70.09 1 Day -0.31 -0.46
Low 67.12 1 Week 0.00 0.00
Close 67.81 1 Month 0.00 0.00
Volume 21158724 1 Year 7.07 11.64
52 Week High 70.09 | 52 Week Low 60.79
 
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
INTC 45.49 2.52%
 
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
 
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
 
 
AMSG
Daily Charts
AMSG
Intraday Charts
Whats New @
Bazaartrend
AMSG
Free Analysis
 
AMSG Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE70.56
RESISTANCE69.43
SUPPORT66.19
SUPPORT65.06
SUPPORT0.00
SUPPORT0.00
 
AMSG Target for Month April
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
AMSG Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
AMSG Target for Year 2019
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
AMSG Other Details
Segment EQ
Market Capital 886384896.00
Sector Healthcare
Industry Hospitals
Offical website http://www.amsurg.com
 
AMSG Address
AMSG
20 Burton Hills Boulevard
Suite 500
Nashville, TN 37215
United States
Phone: 615-665-1283
Fax: 615-665-0755
 
AMSG Latest News
 
Your Comments and Response on Amsurg Corp.
 
AMSG Business Profile
AmSurg Corp., incorporated on the March 06, 1992, is the owner and operator of short stay ambulatory surgery centers (ASCs) in the United States. An AmSurg surgery centers are typically located adjacent to or in close proximity to the medical practices of its partner physicians. The Company generally owns a 51% interest in the facilities the Company operates. Its surgical facilities primarily provide non-elective, high volume, lower-risk surgical procedures across multiple specialties, including among others gastroenterology, ophthalmology, and orthopedics. For the year ended December 31, 2012, approximately 1.5 million surgical procedures were performed in its ASCs. As of December 31, 2012, the Company operated 240 ASCs, of which the Company owned a majority interest (primarily 51% or greater) in 235 ASCs and a minority interest in five ASCs (three of which are consolidated). During December 31, 2012, 149 centers performed gastrointestinal endoscopy procedures, 48 centers performed procedures in multiple specialties, 36 centers performed ophthalmology surgery procedures, and seven centers performed orthopedic procedures. The types of procedures performed at each center depend on the specialty of the practicing physicians. The procedures performed at the Company’s surgery centers include gastroenterology (colonoscopy and other endoscopy procedures), ophthalmology (cataracts and retinal laser surgery) and orthopedic (knee and shoulder arthroscopy, and carpal tunnel repair). As of December 31, 2012, approximately 77% of the Company’s revenues are from single-specialty centers that perform gastroenterology or ophthalmology procedures. The Company also focuses on developing and operating centers, including contracting with vendors and third-party payors. In a development project, the Company provides services, such as financial feasibility pro forma analysis, site selection, financing for construction, equipment and build out, and architectural oversight. Capital contributed by the physicians and AmSurg plus debt financing provides the funds necessary to construct and equip a new surgery center and initial working capital.
 
2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service